Predictions
Johnson & Johnson
Start price
Target price
Perf. (%)
€138.90
05.02.21
05.02.21
-
31.12.21
31.12.21
0.09%
29.03.21
29.03.21
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
Johnson & Johnson
Start price
Target price
Perf. (%)
€134.68
20.01.21
20.01.21
€144.00
0.89%
02.02.21
02.02.21
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
Pfizer Inc.
Start price
Target price
Perf. (%)
€31.01
18.12.20
18.12.20
€34.00
18.12.21
18.12.21
-5.35%
15.03.21
15.03.21
Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Pfizer Inc.
Start price
Target price
Perf. (%)
€30.91
17.12.20
17.12.20
€29.00
-1.81%
21.12.20
21.12.20
Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Pfizer Inc.
Start price
Target price
Perf. (%)
€35.01
12.12.20
12.12.20
-
12.12.21
12.12.21
-14.23%
24.03.21
24.03.21
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Pfizer Inc.
Start price
Target price
Perf. (%)
€31.50
30.11.20
30.11.20
€38.00
30.11.21
30.11.21
18.40%
02.08.21
02.08.21
Could be worthwhile Investment >10% per year
Very high dividend yield expected
Fair valuation
Higher EBIT margin than peer group
Pfizer Inc.
Start price
Target price
Perf. (%)
€31.40
18.11.20
18.11.20
-
18.11.21
18.11.21
45.06%
19.11.21
19.11.21
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Low dividend yield expected
Pfizer Inc.
Start price
Target price
Perf. (%)
€33.30
09.11.20
09.11.20
€37.95
-11.94%
17.12.20
17.12.20
Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Pfizer Inc.
Start price
Target price
Perf. (%)
€30.93
25.08.20
25.08.20
€25.62
03.09.20
03.09.20
-2.45%
03.09.20
03.09.20
Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Pfizer Inc.
Start price
Target price
Perf. (%)
€30.93
04.08.20
04.08.20
€38.00
04.11.21
04.11.21
0.31%
13.04.21
13.04.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Pfizer Inc.
Start price
Target price
Perf. (%)
€29.70
16.07.20
16.07.20
€33.21
25.08.20
25.08.20
4.15%
25.08.20
25.08.20
Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Pfizer Inc.
Start price
Target price
Perf. (%)
€28.65
12.07.20
12.07.20
-
17.10.20
17.10.20
9.93%
17.10.20
17.10.20
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Pfizer Inc.
Start price
Target price
Perf. (%)
€28.84
01.07.20
01.07.20
€42.69
08.07.20
08.07.20
-2.30%
08.07.20
08.07.20
Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€264.80
05.06.20
05.06.20
€290.00
12.10.20
12.10.20
5.70%
12.10.20
12.10.20
Pfizer Inc.
Start price
Target price
Perf. (%)
€27.04
17.03.20
17.03.20
€33.21
04.11.21
04.11.21
47.75%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Johnson & Johnson
Start price
Target price
Perf. (%)
€117.78
11.03.20
11.03.20
€150.00
04.11.21
04.11.21
20.58%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€83.00
22.12.19
22.12.19
€79.00
04.11.21
04.11.21
-3.61%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€224.77
25.06.19
25.06.19
€270.60
06.09.19
06.09.19
-7.88%
06.09.19
06.09.19
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€216.11
10.03.19
10.03.19
€239.03
12.07.19
12.07.19
10.11%
12.07.19
12.07.19
Could be worthwhile Investment >10% per year
Johnson & Johnson
Start price
Target price
Perf. (%)
€124.68
01.03.19
01.03.19
€130.79
11.03.20
11.03.20
-5.54%
11.03.20
11.03.20
Could be worthwhile Investment >10% per year
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€71.50
01.03.19
01.03.19
€77.00
04.11.21
04.11.21
-1.04%
26.10.21
26.10.21
Could be worthwhile Investment >10% per year